Delivery Order SPE2DP20D0002-SPE2DP20F6212
Award Date 7/22/20
Potential Completion Date 7/28/20
Potential Value $271K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract is a firm-fixed-price delivery order with a potential value of $271,494.00 and a completion date of December 15, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has provided various pharmaceutical products, including vaccines, antiviral...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The Firm Fixed Price contract has a potential value of $135,747.00 and a completion date of November 17, 2020. It was awarded on November 3, 2020, and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The delivery order has a firm-fixed-price contract type and a potential value of $952,828.38. It is scheduled for completion on February 27, 2024. This award is not a set-aside contract. Teva Pharmaceuticals USA, Inc. has been awarded multiple prime federal contracts...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $635,218.92 and a period of performance ending on November 19, 2024. The award is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a major pharmaceutical supplier to federal agencies,...
- This is a delivery order awarded to Teva Pharmaceuticals USA, Inc. by the Defense Logistics Agency Troop Support Medical, with a completion date of April 27, 2021. The order is for $282,353.76 to provide Adenovirus Type 4 vaccine, under a firm-fixed-price contract. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products, including vaccines, antivirals, and respiratory treatments, that has supplied the U.S. government, including the Department of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to supply Adenovirus Type 4 vaccine. The $282,353.76 contract has a completion date of January 26, 2021. Teva Pharmaceuticals is a foreign-owned, for-profit organization that provides a range of drug products to federal agencies, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. The...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. This delivery order has a completion date of January 30, 2024. Teva Pharmaceuticals USA, Inc. is the prime contractor and there is no set-aside designation for this award. The company has previously fulfilled multiple federal contracts and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $141,176.88 firm fixed-price contract is for the delivery of adenovirus type 4 vaccines, with a completion date of March 23, 2021. The award is not associated with a set-aside for small businesses or other socioeconomic programs. Teva has an extensive history of providing pharmaceutical products, including...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract has a firm fixed price of $423,530.64 and a completion date of February 23, 2021. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that produces a range of drug products, including vaccines, for U.S. government agencies like the Department of Defense...